Signal active
Bio
Joseph Edelman founded Perceptive Advisors, LLC in 1999, a hedge fund focused on supporting the progress of the life sciences industry. Under Joe’s leadership, Perceptive has grown into one of the largest and most successful life sciences funds with over $2 billion of assets under management by applying thorough due diligence and insights in assessing technologies for investment. The firm oversees a portfolio of investments in various therapeutic areas across all stages of development and commercialization. Perceptive has increasingly led seed and early financing rounds in private life sciences companies from company formation through the development life cycle. Previously, Joe was Senior Analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund, from 1994 through 1998. Prior to Aries Fund, he was Senior Biotechnology Analyst at Prudential Securities for four years, after starting his career in the healthcare sector of the securities industry as Biotechnology Analyst at Labe, Simpson. Joe earned an MBA from New York University and a BA, magna cum laude, in psychology from the University of California, San Diego.
Location
New York, New York, United States, North America
Social
Primary Organization
1999
277
95
144
11-50
Financial Services, Venture Capital, Finance
Jobs history
4
Prudential Securities
Senior Biotechnology Analyst
1990 - 1994
New York Genome Center
Board if Directors
Invalid date - Current
Brown University
Board of Trustees
2019 - Current
Athira Pharma
Board Member
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Joseph Edelman is the CEO & Founder at Perceptive Advisors, based in New York, New York, United States, North America. With a background in Financial Services, Joseph Edelman has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
7
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Jul 23, 2019 | Frequency Therapeutics | Series C - Frequency Therapeutics | Perceptive Advisors | 0 |
Jun 04, 2020 | Athira Pharma | Series B - Athira Pharma | Perceptive Advisors | 85.0M |
Jul 17, 2020 | Frequency Therapeutics | Post-IPO Equity - Frequency Therapeutics | Perceptive Advisors | 42.3M |
Feb 28, 2024 | Crinetics Pharmaceuticals | Post-IPO Equity - Crinetics Pharmaceuticals | Perceptive Advisors | 350.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.